Collegium Pharma News and Activities
Presence
Collegium Pharma develops and sells prescription medicines for pain and related conditions. Its products and support services mainly serve healthcare providers, pharmacies, and adult patients in the United States.
Collegium Pharma products and services overview:
- Pain medicines
- Addiction treatment
- CNS therapies
- Prescription drugs
- Patient support
Revenue: ~$604 million
Employees: 450
Headquarters: Stoughton, United States (USA)
Collegium Pharma is one of the...
Collegium Pharma is a company listed under the stock ticker COLL (US).
Executives
View the org chart displaying its 23 main executives
Most searched biographies at Collegium Pharma
- Vikram Karnani, President and Chief Executive Officer
- Gino Santini, Chairman of the Board
- John Fallon, Director
Create your alert
to follow the executive moves at Collegium Pharma.
Pharmaceuticals
Collegium Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Collegium Pharma
- Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022 - Collegium Pharmaceutical Inc.
- Collegium to Participate in H.C. Wainwright Global Investment Conference - Collegium Pharmaceutical Inc.
- Collegium Reports First Quarter 2022 Financial Results - Collegium Pharmaceutical Inc.
- Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results - Collegium Pharmaceutical Inc.
- Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation - Collegium Pharmaceutical Inc.
- Collegium Appoints Rita Balice-Gordon to its Board of Directors - Collegium Pharmaceutical Inc.
- Collegium Announces Five Posters Presented at PAINWeek 2020 National Conference - Collegium Pharmaceutical Inc.
- Collegium Announces Scientific Presentations at PAINWeek 2020 National Conference - Collegium Pharmaceutical Inc.
- Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020 - Collegium Pharmaceutical Inc.
- Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update - Collegium Pharmaceutical Inc.
- View more press releases Close
Social media about Collegium Pharma
- Collegium Pharma on Wikipedia, Google News & Yahoo Finance
- Collegium Pharma on LinkedIn, X (Twitter) & YouTube
